Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
about
Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's SyndromeBiologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's SyndromeAnti-TNF-alpha therapy and systemic vasculitis.Profile of adalimumab and its potential in the treatment of uveitisBayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivoImmunopathogenesis of ocular Behçet's diseaseSimilarities and differences between Behçet's disease and Crohn's disease.Autoimmune and autoinflammatory mechanisms in uveitis.Systemic therapies for inflammatory eye disease: past, present and futureCombination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.Thrombosis in vasculitis: from pathogenesis to treatment.New insights in the clinical understanding of Behçet's disease.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.Development of Immunopathogenesis Strategies to Treat Behçet's Disease.Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.Paediatric Behçet's disease: a UK tertiary centre experienceEvidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.A review and update on orphan drugs for the treatment of noninfectious uveitisCharacteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.Update on the therapy of Behçet disease.Road to remission: a comprehensive review of therapy in uveitis.Etanercept: efficacy and safety for approved indications.Biological agents for the treatment of uveitis.Biologics in oral medicine: ulcerative disorders.Light on the horizont: biologicals in Behçet uveitis.Adalimumab for the treatment of Behçet's disease: experience in 19 patients.TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.Differential diagnosis and management of Behçet syndrome.Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.Current and future treatments for Behçet's uveitis: road to remission.Approaches to immunosuppression in Behçet's disease.Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.Improved clinical control of a challenging case of Behçet's disease with rituximab therapy.Diagnosis and management of Neuro-Behçet's disease: international consensus recommendationsEfficacy and safety of etanercept in chronic immune-mediated disease.New pharmacotherapy options for noninfectious posterior uveitis.
P2860
Q24187204-AFEF6911-BBA8-46EC-B0FA-F8CE95326B97Q24198961-F73C51AD-8127-432B-92A7-4CF186C11479Q27687590-49F12EEA-BE3B-4082-9E1E-0EE270BCAAE7Q28077781-EC9966AA-6C73-4A2A-8216-9F6042B29CB7Q28393589-A867F183-E877-4D60-B7EB-8E1B91F2B880Q33908937-01CADA9C-E6F2-4AA4-B262-2C1F5D643F49Q34048005-E018B174-D469-4434-9CF5-65A7F075D3CDQ34294964-10139B76-7E4D-4761-BD07-0DC02217A436Q34687332-0B4EB0B9-DF50-4C56-831E-FDB3BDA3D186Q35062816-C3A7D4B8-9D7E-4632-93D1-1E8433EDB904Q35440601-C816D700-5558-4B4D-947C-C52C172C1865Q35648227-122DFA4E-5E25-486F-973C-FD575A55A6A2Q35868282-4B23255A-FE05-48AB-A609-196D25F78AB8Q35884889-E0D50E5C-CF92-490F-9B3F-26D073F34105Q36280040-0BECF4BC-2277-4D6E-8AD8-22D54495C7C7Q37003609-2A86F322-8713-4C01-8BFC-0ED0F4E980EFQ37105146-AB9A54BA-DA48-4DC7-81D7-27083FF792C7Q37273484-DB706718-02F2-4565-9A09-A24BB08D146DQ37539557-06D2537B-1628-4369-BB29-2132E952C511Q37561994-6912AC35-5135-415D-9F88-A2088914FB56Q37616430-9B90BF25-5AC5-4CA5-8588-DBE64CAD3DDFQ37632096-F6270726-E2B6-4E21-B495-080D7366B143Q37684328-B52F8957-0DDB-4CC0-87A0-D8C679C57AD9Q37712230-386B90FB-0147-4C7A-ABE3-D18501DC8457Q37936459-8BF1AA5B-F25B-4ADC-A0FC-1AFFE8B43D7BQ37954714-22DCBC27-29B1-410C-9272-FC8D70B4F22FQ37984565-7FAC94A2-5BDD-453B-ABE0-BA1E633DF66EQ37999475-AE93514F-82D0-4890-B7D1-263194D00031Q38004097-D1748599-617E-4D65-95F5-A812F047C626Q38020828-40C461F0-35AD-416B-8DE4-D5F021A2B44DQ38041477-AED6931D-6911-40A2-B6F4-38029353B70BQ38046118-2C6F8DB9-AD82-4F0A-BEF1-DE05EB27F158Q38097750-E5C58805-78DC-4DE5-B73F-E35842A303D4Q38111308-FBE9EE29-E1D9-4948-8B6D-BCC3FCBC2A01Q38119551-B1A77592-9224-413B-A9F8-9548AEA800BDQ38164832-48B287E6-BA64-4990-9AD1-8E4D86FE8C18Q38168707-51211FF4-530F-4834-91B7-407DA142071FQ38173702-B28E23C9-BFD4-4DDE-954E-47FCE463ED09Q38198080-996B0107-6B70-4EDD-ACEB-6F4AF107982CQ38253095-B89C61EC-19F8-4A7C-AE6C-B71CFE1A98FC
P2860
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@ast
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@en
type
label
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@ast
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@en
prefLabel
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@ast
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@en
P2093
P921
P1476
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
@en
P2093
Aikaterini Arida
Eirini Giavri
Kalliopi Fragiadaki
Petros P Sfikakis
P356
10.1016/J.SEMARTHRIT.2010.09.002
P577
2010-12-17T00:00:00Z